SARS-CoV-2 genome datasets analytics for informed infectious disease surveillance

Abstract

Background: The COVID-19 pandemic has ravaged economies, health systems, and lives globally. Concerns surrounding near total economic collapse, loss of livelihood and emotional complications ensuing from lockdowns and commercial inactivity, resulted in governments loosening economic restrictions. These concerns were further exacerbated by the absence of vaccines and drugs to combat the disease, with the fear that the next wave of the pandemic would be more fatal. Consequently, integrating disease surveillance mechanism into public healthcare systems is gaining traction, to reduce the spread of community and cross-border infections and offer informed medical decisions. Methods: Publicly available datasets of coronavirus cases around the globe deposited between December, 2019 and March 15, 2021 were retrieved from GISAID EpiFluTM and processed. Also retrieved from GISAID were data on the different SARS-CoV-2 variant types since inception of the pandemic. Results: Epidemiological analysis offered interesting statistics for understanding the demography of SARS-CoV-2 and helped the elucidation of local and foreign transmission through a history of contact travels. Results of genome pattern visualization and cognitive knowledge mining revealed the emergence of high intra-country viral sub-strains with localized transmission routes traceable to immediate countries, for enhanced contact tracing protocol. Variant surveillance analysis indicates increased need for continuous monitoring of SARS-CoV-2 variants.  A collaborative Internet of Health Things (IoHT) framework was finally proposed to impact the public health system, for robust and intelligent support for modelling, characterizing, diagnosing and real-time contact tracing of infectious diseases. Conclusions: Localizing healthcare disease surveillance is crucial in emerging disease situations and will support real-time/updated disease case definitions for suspected and probable cases. The IoHT framework proposed in this paper will assist early syndromic assessments of emerging infectious diseases and support healthcare/medical countermeasures as well as useful strategies for making informed policy decisions to drive a cost effective, smart healthcare system.